Introduction
The decision to bring pregnancy to an end before the spontaneous onset of labor is one of the most drastic ways of intervening in the natural process of pregnancy and childbirth. The reasons given for elective delivery (which may be achieved either by inducing labor or by elective cesarean section) range from the life-saving to the trivial. There has been very little methodologically sound research on the indications for elective delivery; most of the research has been concerned with the methods to achieve it. Although comparisons of these methods are secondary to the more fundamental question of when or whether an elective delivery is required, once the decision for an elective delivery is made, the method chosen becomes important.
Assessing the cervix
The state of the cervix at the time of induction is one of the most important determinants of the subsequent course of events. An 'unripe' cervix (one which is not ready for induction of labor) fails to dilate adequately in response to uterine contractions. Attempted induction when the cervix is not ripe may result in high rates of induction failure, protracted and exhausting labors, a high cesarean-section rate, and other complications, such as intra-uterine infection when amniotomy is employed, as well as uterine hypertonus and other complications with the use of oxytocics.
Assessment of the state of the cervix is highly subjective and even experienced examiners may differ in their appraisal of cervical features. Several scoring systems have been developed in attempts to establish more comparable guidelines for cervical assessment. The best known of these is the score proposed by Bishop, which rates five different qualities: effacement, dilatation, and consistency of the cervix; position of the cervix relative to the axis of the pelvis; and descent of the fetal presenting part. Most other scoring systems use the same components, although with different weighting. There is some evidence that cervical dilatation alone is more predictive of subsequent progress than the composite score
As there is considerable overlap between the processes of cervical ripening and labor induction, this chapter should be read in conjunction with chapter 40 (methods of inducing labor).
Prostaglandins for cervical ripening
Doses of prostaglandins, which by themselves are insufficient to induce labor successfully, produce a marked softening of the uterine cervix. This softening results more from an effect on the cervical connective tissue than from uterine contractions.
Prostaglandins can effectively ripen the cervix and facilitate induction of labor. Labor commences before the start of induction (during the period allocated for cervical ripening) more often in women receiving prostaglandins for cervical ripening than in women who receive placebo or no specific treatment. Prostaglandin-ripening of the cervix increases the likelihood of a successful induction of labor, and of achieving vaginal birth within 12 or 24 hours.
The effect of prostaglandin-ripening on the pain experienced during labor is not clear. The few reports that provide data on the use of pharmacological or epidural analgesia show that epidural analgesia is less frequently used among prostaglandin-treated women than among women in the control groups, which at least suggests that these women may experience less pain.
'Uterine hypertonus' or 'uterine hyperstimulation' (excessive uterine contractility), either during the period of cervical ripening or during the subsequent induction of labor, occurs more often in prostaglandintreated women than among women who receive placebo or no treatment prior to induction. Whether for this or for other reasons, fetal heart-rate abnormalities also tend to occur more frequently with prostaglandin treatment. Neither of these trends lead to an increased incidence of operative delivery. On the contrary, prostaglandin treatment reduces the rate of operative delivery with a modest but statistically significant decrease in the cesarean-section rate and a more marked decrease in the rate of instrumental vaginal delivery.
Few trials provide data on the incidence of postpartum hemorrhage and/or the use of blood transfusion. The available data do not suggest that these outcomes are influenced by the use of prostaglandins for cervical ripening, but the estimates are not precise.
None of the data available suggest any influence, good or bad, of cervical ripening on neonatal outcomes. There is a trend towards fewer low Apgar scores in babies born to mothers who received prostaglandins but few trials provide data on more substantive infant outcome measures, such as resuscitation of the newborn, admission to a special care nursery, and perinatal death.
Oral prostaglandins
Oral prostaglandin E 2 has been shown to be little or no better than either placebo or no treatment for cervical ripening. The synthetic prostaglandin E 1 analog misoprostol, administered orally, appears to be effective both for cervical ripening and induction of labor but there are inadequate data on its safety (see Chapter 40).
Vaginal prostaglandins
Vaginal administration of prostaglandins for cervical ripening has been studied more extensively than oral administration. The results show an increase in the frequency of labor onset during the ripening period, a decrease in the incidence of failed induction, and an increase in the likelihood of 'hypertonus' or 'hyperstimulation' . The rate of both instrumental vaginal delivery and cesarean section is decreased with the use of vaginal prostaglandins. No effect has been demonstrated on any infant outcomes.
Women receiving vaginal prostaglandins for cervical ripening are more likely to undergo cesarean section during the time interval allowed for cervical ripening than women receiving the control treatment. This higher incidence of cesarean section during cervical ripening is more than compensated for by a lower cesarean-section rate during induced labor.
Of the many preparations used for vaginal administration, the modern gel and pessary preparations are more effective than the tablet forms previously used. Vaginal administration of misoprostol is discussed in Chapter 40.
Endocervical prostaglandins
Evaluations of prostaglandins administered in a viscous gel in the cervical canal have been conducted mostly with 0.5 mg PGE 2 , a dose that is much smaller than is used with either the oral or vaginal routes of administration. Endocervical prostaglandin administration is more likely than either placebo or no treatment to result in uterine activity, in the onset of labor, in a reduction of the need for formal induction of labor at the end of the ripening period, and in delivery during the ripening period. As with vaginal prostaglandins, more women undergo cesarean section during the ripening period, but this is again compensated for by a reduction in the rate of cesarean during labor. The likelihood of failed induction is reduced, as is the rate of operative delivery.
Extra-amniotic prostaglandins
Few placebo-controlled trials have evaluated extra-amniotic administration of a prostaglandin for cervical ripening. The few data available do not permit adequate judgement about the relative merits or hazards of this specific route of administration.
Direct comparisons between different routes
Controlled comparisons of endocervical with vaginal PGE 2 gel for cervical ripening suggest that the endocervical approach results in more women going into labor or delivering during ripening (if this is considered to be a desirable outcome). No statistically significant differences are found in any other outcomes. The choice between these approaches may be best determined by clinical preference.
Labor is more likely to occur during ripening with the use of extraamniotic rather than vaginal or endocervical prostaglandins. No differential effects on other outcome measures have been found in the few controlled trials that have been conducted, but the trials were too small to detect modest differences.
Other methods for cervical ripening

Estrogens
The use of estrogens for cervical ripening has been suggested on the theoretical grounds that these agents might ripen the cervix without concomitant effects on uterine contractility. Data from controlled trials with a variety of estrogenic preparations, failed to show any beneficial effects.
Oxytocin
Oxytocin infusions for prolonged periods of time (as is usually the case when the aim is to ripen the cervix) are unpleasant, limit the woman's mobility, and may lead to water intoxication when administered in large doses. Oxytocin administration to ripen the cervix (rather than to induce labor) serves no useful purpose and should be abandoned.
Mechanical methods
Mechanical devices, such as catheters with or without extra-amniotic saline infusion, laminaria tents, and synthetic hydrophylic materials, have been shown to increase cervical ripeness scores and may increase the proportion of women going into labor. No effect has been shown on the incidence of operative delivery, puerperal fever, or low Apgar scores.
Several recent trials have shown little difference, if any, in effects between various mechanical methods and prostaglandins administered vaginally or intracervically, but all of these trials have been small. Factors to be taken into account when choosing a method of cervical ripening are, on the one hand, that mechanical methods are more uncomfortable to apply, while on the other hand, they are less expensive and less likely to cause uterine hyperstimulation than prostaglandins.
Relaxin
The use of porcine relaxin to soften the cervix and shorten labor had a brief vogue of popularity in the 1950s. Placebo-controlled trials failed to show any benefit.
Recent trials with a purer preparation and recombinant human relaxin have also failed to demonstrate any useful effects. Relaxin should not be adopted into clinical practice unless large, properly controlled trials show evidence of benefit.
Breast stimulation
In an attempt to explore 'natural' methods for ripening the cervix, two groups of investigators have evaluated the effects of breast stimulation. Both reported that women allocated to breast stimulation were more likely to go into labor during the intervention period than those allocated to the control group, but there was no suggestion as to whether this resulted in easier labor or delivery.
Prostaglandins versus other methods
A number of small trials have compared prostaglandins with alternative agents for cervical ripening, including oxytocin and estrogens. None of these trials were large enough to provide useful estimates of effect, either individually or by combining their data. The general conclusion derived from these studies suggests that prostaglandins are more effective than the other agents.
Hazards of cervical ripening
Increasing the readiness of the cervix for induction is not a trivial intervention. Depending on the method used, the risks of the ripening include a (small) danger of intra-uterine infection with mechanical procedures and extra-amniotic drug administration, an increased likelihood of uterine hypertonus and fetal heart-rate abnormalities, and a certain amount of discomfort and inconvenience for the mother. Some of these hazards, uterine hypertonus and fetal heart-rate abnormalities in particular, are ill-defined and of unclear significance but they have sometimes prompted cesarean sections during cervical ripening.
The risks of cervical ripening are not limited to those related to the intervention itself but include those associated with induction of labor. The greatest hazard is that the ease of cervical ripening may result in unnecessary induction of labor in women for whom an artificial ending of pregnancy would not otherwise have been contemplated.
Conclusions
No attempts should be made to ripen the cervix, unless there are valid grounds for ending pregnancy artificially. None of the successful methods of cervical ripening act exclusively on the cervix and all of them tend to increase myometrial contractility.
When it is necessary to induce labor in the presence of an 'unripe' cervix, the method used should not only increase cervical readiness, but must also increase the likelihood of spontaneous vaginal birth of a healthy baby within a reasonable period of time and involve minimal inconvenience or discomfort for the mother.
Use of prostaglandins decreases the likelihood of 'failed induction' , decreases the incidence of prolonged labor, and increases the chances of a spontaneous vaginal birth. There are still insufficient data to allow any confident conclusions about the effects on the baby.
Oral administration of prostaglandins, other than misoprostol, has no value for ripening the cervix. Extra-amniotic administration, if used at all, should be reserved for women with very 'unripe' cervices and for those who are unlikely to respond adequately to vaginal or endocervical administration.
Vaginal and endocervical administration of prostaglandin PGE 2 in gel or pessary form are the current methods of choice. The two forms of administration seem equally effective. The vaginal route has the advantage of ease of application.
Recent reports have demonstrated the effectiveness of mechanical methods, particularly those employing a catheter balloon, though the discomfort caused by insertion may limit the acceptability of these methods.
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